Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jonathan Wolleben is an analyst at JMP Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/14/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/07/2024 | SGMT | Buy Now | Sagimet Biosciences | $4.20 | 1042.94% | $48 → $48 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/04/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $45.33 | 76.48% | $80 → $80 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/31/2024 | LRMR | Buy Now | Larimar Therapeutics | $9.25 | 170.27% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/24/2024 | SGMT | Buy Now | Sagimet Biosciences | $4.20 | 1042.94% | $48 → $48 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/21/2024 | LRMR | Buy Now | Larimar Therapeutics | $9.25 | 170.27% | → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/10/2024 | GPCR | Buy Now | Structure Therapeutics | $51.64 | 76.22% | → $91 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/10/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $45.33 | 76.48% | → $80 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/10/2024 | ALT | Buy Now | Altimmune | $6.16 | 289.61% | $25 → $24 | Maintains | Market Outperform | Get Alert |
| 05/09/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $25.92 | 154.63% | $72 → $66 | Maintains | Market Outperform | Get Alert |
| 05/08/2024 | PTGX | Buy Now | Protagonist Therapeutics | $33.39 | 34.77% | $42 → $45 | Maintains | Market Outperform | Get Alert |
| 05/08/2024 | OCUL | Buy Now | Ocular Therapeutix | $5.81 | 278.66% | $24 → $22 | Maintains | Market Outperform | Get Alert |
| 05/08/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $279.50 | 36.31% | $397 → $381 | Maintains | Market Outperform | Get Alert |
| 05/07/2024 | BCRX | Buy Now | BioCryst Pharma | $6.19 | 142.38% | $14 → $15 | Maintains | Market Outperform | Get Alert |
| 05/06/2024 | SVRA | Buy Now | Savara | $4.25 | 88.24% | → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/19/2024 | SVRA | Buy Now | Savara | $4.25 | 88.24% | → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/19/2024 | RLYB | Buy Now | Rallybio | $1.50 | 433.33% | → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/18/2024 | SVRA | Buy Now | Savara | $4.25 | 88.24% | → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/18/2024 | RLYB | Buy Now | Rallybio | $1.50 | 433.33% | → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/16/2024 | OCUL | Buy Now | Ocular Therapeutix | $5.81 | 313.08% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/11/2024 | PHVS | Buy Now | Pharvaris | $18.10 | 176.24% | $49 → $50 | Maintains | Market Outperform | Get Alert |
| 03/28/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $45.33 | 76.48% | → $80 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/20/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $45.33 | 76.48% | $60 → $80 | Maintains | Market Outperform | Get Alert |
| 03/15/2024 | LRMR | Buy Now | Larimar Therapeutics | $9.25 | 170.27% | → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $279.50 | 42.04% | — | Maintains | Outperform | Get Alert |
| 03/14/2024 | SPRB | Buy Now | Spruce Biosciences | $0.64 | 368.75% | $8 → $3 | Maintains | Market Outperform | Get Alert |
| 03/14/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $25.92 | 177.78% | $69 → $72 | Maintains | Outperform | Get Alert |
| 03/13/2024 | RLYB | Buy Now | Rallybio | $1.50 | 433.33% | → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | OCUL | Buy Now | Ocular Therapeutix | $5.81 | 313.08% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | CLSD | Buy Now | Clearside Biomedical | $1.17 | 327.17% | → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/12/2024 | OCUL | Buy Now | Ocular Therapeutix | $5.81 | 313.08% | $12 → $24 | Maintains | Market Outperform | Get Alert |
